Fortitude Family Office’s Beta Bionics BBNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.93K Buy
+187
New +$2.22K ﹤0.01% 1320
2025
Q3
Sell
-35
Closed -$510 2167
2025
Q2
$510 Buy
+35
New +$495 ﹤0.01% 1804

Other funds holding BBNX

Fortitude Family Office's BBNX Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Beta Bionics (BBNX) in Q2 2026: 187 shares worth $2.93K. The stake represents ﹤0.01% of the portfolio and ranks #1320 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in BBNX as recently as Q2 2025.

Fortitude Family Office first reported a position in BBNX in Q2 2025 and has held it in 2 quarters since. 23 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Fortitude Family Office held 187 shares of Beta Bionics worth $2.93K as of Q2 2026.
  • Beta Bionics was a new Fortitude Family Office position in Q2 2026.
  • Beta Bionics made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1320 holding.
  • Fortitude Family Office first reported a position in Beta Bionics in Q2 2025 and has held it in 2 quarters since.
  • 23 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.